NOX4/Keap1/Nrf2/ROS signaling drives ferroptosis in trimethyltin chloride-induced cardiac developmental malformations

Jin Chen1, Hanwen Hu1, Jing Fu1

  • 1School of Public Health, North Sichuan Medical College, Nanchong, Sichuan 637100, China.

Toxicology
|January 4, 2026
PubMed

Insights

Trimethyltin chloride (TMT) causes heart defects by triggering ferroptosis, a cell death pathway. This occurs through the NOX4/Keap1/Nrf2/ROS signaling axis, highlighting TMT

Area of Science:

  • Toxicology
  • Developmental Biology
  • Cell Death Research

Background:

  • Trimethyltin chloride (TMT) is an environmental pollutant linked to cardiac injury.
  • The mechanisms of TMT-induced cardiotoxicity, particularly ferroptosis, are not fully understood.
  • NADPH oxidase 4 (NOX4) and the Keap1/Nrf2 pathway are key regulators of reactive oxygen species (ROS) in the heart.

Purpose of the Study:

  • To investigate the role of NOX4/Keap1/ROS-mediated ferroptosis in TMT-induced cardiac developmental defects.
  • To elucidate the molecular signaling axis involved in TMT cardiotoxicity.

Main Methods:

  • Zebrafish embryos were exposed to TMT to assess cardiac development.
  • Gene expression analysis of nox4, Keap1, Nrf2, and ferroptosis markers.
  • Pharmacological inhibition and genetic knockdown of nox4 and keap1.
  • Intervention with ferroptosis inhibitors (Liproxstatin-1, Myricetin).

Main Results:

  • TMT exposure caused cardiac malformations, edema, and reduced heart rate in zebrafish embryos.
  • TMT upregulated nox4 expression and activated ferroptosis, evidenced by increased ROS, mitochondrial damage, Fe²⁺ accumulation, and decreased GPX4.
  • Inhibition or knockdown of nox4 or keap1 significantly attenuated TMT-induced cardiac defects and ferroptosis.
  • Ferroptosis inhibitors confirmed ferroptosis's direct role in TMT cardiotoxicity.

Conclusions:

  • TMT induces cardiac malformations by activating ferroptosis through the nox4/Keap1/Nrf2/ROS signaling pathway.
  • This study reveals a novel mechanism of TMT cardiotoxicity.
  • Findings suggest TMT exposure as a risk factor for congenital heart disease and identify potential therapeutic targets.